✦ LIBER ✦
5T4-specific antibody responses are associated with survival in a phase II trial of renal cell carcinoma patients vaccinated with modified vaccinia Ankara delivering the tumour antigen 5T4 in combination with low-dose IL-2
✍ Scribed by W.H. Shingler; S. Naylor; J. Hernandez-McClain; R.J. Amato; J. Jac; J. Willis; S. Saxena; R. Harrop
- Book ID
- 119598931
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 89 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.